Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Co-tenidone 50mg/12.5mg tablets
020400040AAAAAA
|
Co-tenidone | Co-tenidone (Atenolol/chlortalidone) | Cardiovascular System | 16,860 |
|
Co-tenidone 100mg/25mg tablets
020400040AAABAB
|
Co-tenidone | Co-tenidone (Atenolol/chlortalidone) | Cardiovascular System | 11,149 |
|
Co-tenidone 100mg/25mg/5ml oral liquid
020400040AAACAC
|
Co-tenidone | Co-tenidone (Atenolol/chlortalidone) | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.